Cargando…
Celastrol Enhances the Anti-Liver Cancer Activity of Sorafenib
BACKGROUND: Sorafenib, a multiple-target-point kinase inhibitor, has been used as a standard treatment for advanced liver cancer and has shown therapeutic benefits. However, resistance often occurs, prompting the need for identification of synergizing agents. Celastrol is a major active ingredient o...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Scientific Literature, Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559000/ https://www.ncbi.nlm.nih.gov/pubmed/31152143 http://dx.doi.org/10.12659/MSM.914060 |